Island Biosurgical Bladder Neck Bolstr Model IBIBOL.002
510(k) K982042
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK982042 | Date8 Sep 1998 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- OTN
- Device Class
- Class II
- Regulation
- 21 CFR Part 878.3300
- Advisory Committee
- General, Plastic Surgery
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 21 Sep 2026
The Island Biosurgical Bladder Neck Bolstr Model IBIBOL.002 is a surgical mesh device classified as Mesh, Surgical, Synthetic, Urogynecologic, For Stress Urinary Incontinence, Retropubic Or Transobturator. It is intended for use in the surgical correction of female stress urinary incontinence due to pelvic relaxation.
The device is supplied by Island Biosurgical, Inc. and was cleared via the FDA 510(k) pathway under K982042 with a decision date of September 8, 1998. It is classified as a Class II medical device under regulation number 878.3300 and product code OTN, with a review panel designation of Gastroenterology/Urology (GU).
Other devices from Island Biosurgical, Inc.
Questions
AI-generated answers, 21 Sep 2026
What is the Island Biosurgical Bladder Neck Bolstr Model IBIBOL.002 used for?
It is intended for use in the surgical correction of female stress urinary incontinence due to pelvic relaxation, as a synthetic urogynecologic mesh device implanted via retropubic or transobturator approach.
How is the Island Biosurgical Bladder Neck Bolstr Model IBIBOL.002 supplied and is it sterile?
The device is supplied by Island Biosurgical, Inc., but the provided data does not specify sterility status, single-use or reusable designation, or packaging details; therefore, sterility and supply format cannot be confirmed from the given information.
What regulatory pathway cleared the Island Biosurgical Bladder Neck Bolstr Model IBIBOL.002 and when?
It was cleared via the FDA 510(k) traditional pathway under submission K982042, with a decision date of September 8, 1998, and found substantially equivalent to a predicate device.